Latest total liabilities for INDOUS.NS: $480M.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
As of the most recent data (September 2026), INDOUS.NS shows a total liabilities of $480M. That compares with $310M in the prior-year period — up 58.6% year over year. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, INDOUS.NS's total liabilities is now $480M (was $310M) — a 58.6% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Indo US Bio-Tech Limited is outperforming or lagging.
Tracking INDOUS.NS's total liabilities over time shows whether Indo US Bio-Tech Limited is scaling, shrinking, or reshaping that part of the business. The current reading is $480M That compares with $310M in the prior-year period — up 58.6% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.
Besides this total liabilities page, Stockcircle has Indo US Bio-Tech Limited's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total liabilities (currently $480M) with ownership activity and broader fundamentals.